Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial

RATIONALE: Pulmonary coagulopathy may play a pathogenetic role in acute respiratory distress syndrome (ARDS), by contributing to alveolocapillary inflammation and increased permeability. Recombinant human activated protein C (rh-APC) may inhibit this process and thereby improve patient outcome. METH...

Full description

Saved in:
Bibliographic Details
Main Authors: Cornet, Alexander D., Groeneveld, A. B. Johan, Hofstra, Jorrit J., Vlaar, Alexander P., Tuinman, Pieter R., van Lingen, Arthur, Levi, Marcel, Girbes, Armand R. J., Schultz, Marcus J., Beishuizen, Albertus
Format: Artigo
Language:Inglês
Published: Public Library of Science 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3954619/
https://ncbi.nlm.nih.gov/pubmed/24632673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0090983
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items